acetylleucyl-leucyl-norleucinal has been researched along with Alzheimer Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellocq, JP; Boutillier, AL; Boutillier, S; Buée, L; Delacourte, A; Lannes, B; Larmet, Y; Loeffler, JP; Mohr, M; Rouaux, C; Sellal, F | 1 |
Parker, EM; Song, L; Zhang, L | 1 |
Buku, A; Efthimiopoulos, S; Figueiredo-Pereira, ME; Ghiso, J; Mehta, P; Robakis, NK; Tezapsidis, N | 1 |
Duthie, M; Fraser, PE; Holmes, E; Martins, RN; St George-Hyslop, PH; Verdile, G | 1 |
4 other study(ies) available for acetylleucyl-leucyl-norleucinal and Alzheimer Disease
Article | Year |
---|---|
Sp3 and sp4 transcription factor levels are increased in brains of patients with Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Animals, Newborn; Antibodies; Apoptosis; Brain; Case-Control Studies; Cells, Cultured; Cerebellum; Drug Interactions; Gene Expression Regulation; Humans; Leupeptins; Mice; Neurons; Oligopeptides; Postmortem Changes; Sp3 Transcription Factor; Sp4 Transcription Factor; tau Proteins; Time Factors; Transfection | 2007 |
Calpain inhibitor I increases beta-amyloid peptide production by inhibiting the degradation of the substrate of gamma-secretase. Evidence that substrate availability limits beta-amyloid peptide production.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Calpain; Cell Line; Endopeptidases; Gene Expression Regulation; Humans; Leupeptins; Membrane Proteins; Molecular Sequence Data; Mutation; Peptide Fragments; Presenilin-1; Protease Inhibitors; Transfection | 1999 |
Distinct secretases, a cysteine protease and a serine protease, generate the C termini of amyloid beta-proteins Abeta1-40 and Abeta1-42, respectively.
Topics: Aldehydes; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Calpain; CHO Cells; Cricetinae; Cysteine Endopeptidases; Dipeptides; Endopeptidases; Enzyme Inhibitors; Leupeptins; Peptide Fragments; Serine Endopeptidases | 1999 |
Inhibiting amyloid precursor protein C-terminal cleavage promotes an interaction with presenilin 1.
Topics: Alzheimer Disease; Ammonium Chloride; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Cell Line; Centrifugation, Density Gradient; Cysteine Proteinase Inhibitors; Dogs; Endopeptidases; Humans; Leupeptins; Membrane Proteins; Peptide Fragments; Precipitin Tests; Presenilin-1; Transfection | 2000 |